ABSTRACT-Rat urine was found to contain a component showing cross-reactivity with antibody against rat plasma angiotensinogen. Sodium dodecyl sulfate polyacryl amide gel electrophoresis of rat urine revealed antigenic bands corresponding to the molecular weights of plasma angiotensinogen. The urinary angiotensinogen excretion in 8 rats, determined by direct radioimmunoassay, was 2.70 ± 0.21 u g/day. Induction of acute inflammation in rats by injection of lipopolysaccharide caused about a 7-fold increase of urinary angiotensinogen excretion in the 24 hr after injection, with a con comitant elevation of plasma angiotensinogen. Neither sodium depletion nor loading by a low or high-sodium diet altered the urinary excretion of angiotensinogen. These results suggest that the angiotensinogen present in rat urine is derived from that in plasma, although the level of excretion is too low to have any influence on the plasma level of angiotensinogen.
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Angiotensinogen, a plasma protein synthe sized mainly by the liver, is cleaved by renin to release a decapeptide, angiotensin I. Angio tensin I is further hydrolyzed by a converting enzyme to produce the octapeptide, angioten sin II, the biologically active molecule that plays an important role in the regulation of blood pressure and electrolyte balance. Although angiotensinogen mRNA has been identified in several tissues including the liver, kidney, brain, spinal cord, and aorta (1-3), most of the angiotensinogen present in plasma is derived from the liver (4) .
Although factors affecting the hepatic syn thesis of angiotensinogen have been studied extensively (4 6), the mechanisms involved in the clearance of plasma angiotensinogen have never been elucidated. As documented previ ously in several studies, the level of plasma angiotensinogen increases dramatically after bilateral nephrectomy (4, 7) . Although the mechanisms responsible is not completely understood, this increase is thought to be due to enhanced synthesis of angiotensinogen in the liver (8, 9) . However, another possible mechanism in which the kidney carries out in activation and/or excretion of angiotensinogen cannot be excluded. In fact, a recent report by Pedraza-Chaverri et al. have indicated that rat urine contains angiotensinogen (10), as meas ured by assay of angiotensin I liberated after incubation with porcine renin.
To understand the importance of urinary ex cretion of angiotensinogen in regulating the plasma level of this protein, we have studied urinary angiotensinogen in the rat using an anti-rat angiotensinogen antibody.
MATERIALS AND METHODS
Treatment of animals and collection of urine Male F344 rats (Shizuoka Laboratory Ani mal Center, Hamamatsu, Japan), weighing 220-250 g, were used. The rats were housed separately in metabolic cages at 22°C, and 24 hr samples of urine were each collected into a bottle containing 10 ,ug pepstatin and 2 mg sodium azide in 1 ml of distilled water to in hibit the action of renin. Each urine sample was centrifuged at 3,000 X g for 15 min and the supernatant was obtained.
Acute inflammation was induced in rats by a single i.p. injection of lipopolysaccharide (LPS) (Staphylococcus typhosa 0910; Difco, Detroit, U.S.A.) at a dose of 0.5 mg/kg. Dai ly 24-hr urine samples were collected for 4 days. Blood (40,ul) was also collected daily from the tail-tip of each animal into an EDTA-treated capillary tube by cutting with a razor. The tube was centrifuged at 1,000 X g for 20 min, and 15,u l of plasma was obtained.
For the sodium depletion experiment, 8 animals were given furosemide (5 mg, i.p.; Nacalai Tesque, Kyoto, Japan) and then fed a low-sodium diet containing 0.005% sodium (Oriental Yeast, Osaka, Japan) and distilled water for 21 days. Sodium-loading was accom plished by feeding 8 rats a high-sodium diet (1.6%) for 21 days. Twenty-four-hour urine samples and plasma samples were collected on days 14 and 21. For assay of the plasma renin concentration on day 21, the rats were anes thetized with ether, and blood was collected from the abdominal aorta into a syringe con taining a 1/10 volume of 3.8% sodium citrate. Plasma was prepared by centrifugation at 1,000 X g for 20 min.
Radioimmunoassay of angiotensinogen
The angiotensinogen concentration in plas ma or urine was measured by radioimmuno assay using [125I]-labeled rat angiotensinogen and a rabbit antibody against rat angiotensin ogen, as described previously (11) . Assay of angiotensinogen in urine was done immediate ly after collecting the urine sample, since pres ervation of urine at low temperature caused the formation of insoluble precipitates contain ing angiotensinogen.
Immunoaffinity chromatography of rat urine Anti-rat angiotensinogen immunoadsorbent was prepared by mixing 10 ml of Affi-Gel 10 (Bio-Rad, Richmond, CA) in 0.1 M sodium phosphate, pH 7.5, with 90 mg of an IgG preparation obtained from rabbit antiserum against rat angiotensinogen at 4°C for 4 hr. The gel was poured into a column (0.9 X 20 cm) and washed thoroughly with 0.2M glycine-HCI, pH 2.5, followed by 50 mM Tris HCI, pH 7.4, containing 0.15M NaCI, 0.1% Tween 20 and 0.02% sodium azide (equilib rium buffer). The urine sample was applied to the column and then washed with the equilib rium buffer. Adsorbed protein was eluted with 0.2 M glycine-HCI, pH 2.5, and each fraction (2.2 ml) was neutralized by adding 0.75 ml of 1 M Tris-HCI, pH 8.0. Each fraction was sub jected to the assay for angiotensinogen either by the direct method described above or by an indirect method measuring the amount of an giotensin I liberated by renin. In order to de termine angiotensin I liberation, each fraction (100,ul) was mixed with 25,ul of 0.4 M sodium phosphate, pH 6.5, containing 10 mm Na2EDTA, 5 mM o-phenanthroline and 0.5 mM captopril, and 25 ,u l of partially purified rat renin (2,ug), as described previously (12) . The mixture was incubated for 90 min at 37°C followed by addition of 0.1 M Tris-HCI, pH 7.4, containing 0.2% gelatin (200 ,u l) and then heated in boiling water for 3 min. Angiotensin I in the reaction mixture was measured by radioimmunoassay as described previously (12) .
Immunoblot analysis of rat urinary angioten sinogen Rat urine (10 ,ul) and purified plasma angio tensinogen (5 ng) were subjected to SDS polyacrylamide gel electrophoresis in 10% gel according to the method of Laemmli (13) . Purified plasma angiotensinogen was obtained from the plasma of nephrectomized rats as de scribed previously (11) . Western blotting was carried out by electrophoretic transfer to a nitrocellulose filter, and then the filter was soaked in a blocking solution containing 3% gelatin, 20 mM Tris-HCI, pH 7.5, and 0.5 M NaCI for 1 hr. The blot was then soaked in 200-fold-diluted anti-angiotensinogen serum for 2 hr at room temperature, washed with the above buffer containing 0.05% Tween 20, and incubated with horseradish peroxidase-labeled goat anti-rabbit IgG for 1 hr at room tempera ture. Finally, the blot was washed with the above buffer containing 0.5% Tween 20 and processed for color development according to the instruction manual issued by Bio-Rad Laboratories.
Miscellaneous methods
Plasma renin concentration was assayed by measuring the amount of angiotensin I gener ated in plasma supplemented with an excess amount of renin substrate, as described pre viously (14) . Fig. 1 . Displacement of 125I-labeled angiotensinogen bound to antibody with rat plasma angiotensinogen and urine. Purified angiotensinogen from rat plasma (0.0625-250ng,
•) and rat urine (1.25-10,u1, 0) were subjected to angiotensinogen radioimmunoassay. Each point represents the mean of duplicate assays.
RESULTS
Rat urine was found to contain an antigen that reacted with rabbit antibody against rat plasma angiotensinogen. Figure 1 
In order to characterize the angiotensin ogen-like immunoreactivity in rat urine, the 24-hr urine was collected from 4 rats and ap plied directly to a column of anti-angiotensin ogen immunoadsorbent (Fig. 2) . Angiotensin ogen-like immunoreactivity was adsorbed to the column and eluted with 0.2M glycine HCI, pH 2.5. When each fraction was incu bated with an excess amount of rat renin, an giotensin I liberation was observed in fractions containing angiotensinogen-like immunoreac tivity (Fig. 2) . When the adsorbed fractions (fractions number 25 to 35) were pooled and assayed for immunoreactive angiotensinogen and angiotensin I liberation, the adsorbed fractions contained 25.5,ug of immunoreactive angiotensinogen and generated 0.35 pg of an giotensin I through the action of renin. Since the angiotensin I content of the intact form of rat angiotensinogen was expected to be 22.7 ,ug/mg protein, 25.5 ,ug of angiotensinogen in the adsorbed fractions would theoretically re lease 0.58 ug of angiotensin I, suggesting that 60% of the immunoreactive angiotensinogen in rat urine was the intact form of angiotensin ogen, while the remainder was in the form of des-angiotensin I-angiotensinogen. were subjected to SDS-polyacrylamide gel electrophoresis followed by immunoblot analy sis using anti-rat angiotensinogen antibody. As seen in Fig. 3 , the immunoreactivity was local ized in multiple bands between molecular weights of 50,000 and 60,000, which corre sponded to the immunoreactive bands of an giotensinogen purified from rat plasma. Multi ple bands might result from differences in their carbohydrate content which could pro duce a slight change in molecular weight, as reported for plasma angiotensinogen (15) . Thus the immunoreactive substance in rat urine was indistinguishable in its molecular weight from that of plasma angiotensinogen. The amount of angiotensinogen excreted into rat urine was determined by radioimmu noassay to be 2.70 ± 0.21 ug/day (n = 8). Since several plasma proteins including albu min and globulin are excreted into urine to some extent, the angiotensinogen found in urine appeared to be derived from plasma an giotensinogen. To verify this possibility, the urinary excretion of angiotensinogen was de termined in rats after the injection of LPS, since acute inflammation is known to elevate the plasma concentration of angiotensinogen (12, 16) following increased synthesize of an giotensinogen in the liver (6) . As shown in Fig. 4 , the amount of angiotensinogen was in creased approximately 7-fold in 24-hr urine following LPS injection (18.6 ± 3.9,ug com pared with 2.7 ± 0.21,ug). The plasma level of angiotensinogen was also increased from 72.3 ± 10.8 Mg/ml to 180.9 ± 56.9,ug/ml 24 hr after LPS injection (data not shown). The urinary level of angiotensinogen gradually fell to the normal level in 24-hr urine collected in the 48-72-hr period after LPS injection (Fig.  4) . The plasma level of angiotensinogen was also reduced to 78.6 ± 21.2 ,u g/ml after 48 hr. were subjected to SDS-polyacrylamide gel electropho resis in a 10% gel, followed by Western blotting. Anti gen to anti-angiotensinogen antibody was detected im munochemically as described in the text. Fig. 4 . Urinary excretion of angiotensinogen in rats following LPS injection. Rats were injected with LPS (0.5 mg/kg, i.p.) at 0 hr. Samples of 24-hr urine were collected before and after LPS injection .and subjected to angiotensinogen radioimmunoassay. Each bar repre sents the mean ± S.D. for 8 rats. A single or double asterisk indicates significant difference from the level before LPS treatment (*P < 0.01 and **P < 0.001).
Another possible origin of urinary angioten sinogen is the kidney, where angiotensinogen is synthesized (17) and may be secreted into the urine. This possibility was investigated by studying the urinary excretion of angiotensin ogen in rats maintained on a low or high sodium diet, since it has recently been demon strated that the level of angiotensinogen mRNA in rat kidney is increased on a low sodium diet compared with a high-sodium one (18, 19) . As shown in Fig. 5 , there were no differences between sodium-depleted and sodium-loaded rats in the amounts of angio tensinogen excreted into 24-hr urine samples during the 21-day experimental period. The plasma level of angiotensinogen at 14 days was 1.2 times higher in rats maintained on the low sodium diet than that on the high-sodium diet, but there was no difference at 21 days (Fig.  5) . In contrast, plasma renin concentration was about 7 times higher on the low-sodium diet (283 ± 53 ng angiotensin I/ml/hr) than on the high-sodium diet (42 ± 4 ng angiotensin I/ml/hr), as reported previously (20) . In the present study, we demonstrated the presence of angiotensinogen in rat urine on the basis of the following evidence. First, rat urine contained a component that was cross reactive with antibody against rat angiotensin ogen. The fact that the displacement curve of urine paralleled that of plasma angiotensin ogen indicated that the antigen present in urine was immunologically identical to plasma angiotensinogen. Second, the immunoreactive angiotensinogen generated angiotensin I through the action of renin. Third, the molecular weights of the immunoreactive angiotensin ogen in urine could not be distinguished from those of plasma angiotensinogen, as indicated by immunoblot analysis.
Recently, Pedraza-Chaverri et al. reported that both angiotensinogen and renin were ex creted in rat urine (10) . They measured the level of angiotensinogen by assay of angioten sin I after incubation of urine with an excess of porcine renin, and they reported that the urinary level of angiotensinogen in normal rats was 0.028 ,u g angiotensin I/day. We measured urinary angiotensinogen by a direct radioim munoassay, and the level in normal rats was determined to be 2.7,ug angiotensinogen/day, which is equivalent to about 0.06 ,ug angioten sin I/day. Since about 60% of the urinary an giotensinogen was estimated as the intact form of angiotensinogen, our value for the amount of rat urinary angiotensinogen is close to that reported by Pedraza-Chaverri et al.
In order to determine the source of urinary angiotensinogen, we carried out two experi ments: one involved the induction of acute in flammation, which causes elevation of plasma angiotensinogen following increased hepatic synthesis of angiotensinogen (6, 12, 16) , and the other examined the effect of a low or high-sodium diet, which causes an increase or decrease of renal angiotensinogen mRNA, re spectively (18, 19) . It was found that LPS-in duced acute inflammation caused elevation of plasma angiotensinogen with a concomitant in crease in the urinary excretion of angiotensin ogen. On the other hand, low/high dietary sodium did not influence the urinary excretion of this protein, whereas a significant elevation of plasma renin concentration was observed in rats maintained on a low-sodium compared with a high-sodium diet for 21 days, as re ported previously (20, 21) . In rats maintained for 14 days on a low-sodium diet, the plasma level of angiotensinogen was higher than that on a high-sodium diet. The mechanism is un known, but a recent report showed that the angiotensinogen mRNA level in the liver was increased by a low-sodium diet (19) . These re sults indicate that urinary angiotensinogen is derived from plasma angiotensinogen, and not from that synthesized in the kidney.
Little and Sernia measured the production rate and metabolic clearance rate of angioten sinogen in the rat by constant-rate infusion and single injecction of 125I-labeled angioten sinogen (21) . According to their results, the metabolic clearance rate of angiotensinogen was 13 ml plasma/hr/kg, which corresponds to about 230 ,u g angiotensinogen/hr per 250g body weight, since the plasma level of angio tensinogen in the rat was about 70,ug/ml. As urinary excretion of angiotensinogen was about 3 ,ug/24 hr per animal, it is estimated that urinary excretion contributes less than 0.1% to the plasma clearance of angiotensin ogen. Thus it is unlikely that the urinary ex cretion of angiotensinogen is a factor influenc ing the plasma level of this protein, except in some abnormal conditions, including nephrosis (10).
In conclusion, we have demonstrated the presence of angiotensinogen in rat urine, which is indistinguished from plasma angioten sinogen. The data indicate that urinary angio tensinogen is derived from plasma, but that the amount is too small to influence the plasma level of angiotensinogen.
